Key result
Pacemaker implantation without prior HF is linked to a ~21% five-year incidence of new-onset HF.
Why the study?
Although studies show higher risk of new-onset HF after right ventricular pacing, the incidence, risk factors, and long-term prognostic implications of new-onset HF post-implant required investigation.
What is the incidence and what are the risk factors for new-onset heart failure in patients receiving a conventional pacemaker?
Cohort (n=65,579)
Yes
What is the incidence and what are the risk factors for new-onset heart failure in patients receiving a conventional pacemaker?
Conventional pacemaker implantation is associated with a >20% risk of new-onset heart failure within five years, which can be predicted using a novel 9-variable clinical risk score.
Answers are grounded in this paper and cite their sources.
May inform post-pacemaker HF surveillance via risk score; leaves open whether interventions improve outcomes.
BackgroundStudies have shown that the risk of new-onset heart failure (HF) is higher post-implant for patients receiving right ventricular pacing.ObjectiveThis study aimed to investigate incidence, risk factors and implications for long-term prognosis of new-onset HF in patients after pacemaker-implant.MethodsPatients without preexisting HF who received a pacemaker in Sweden during the period 2005-2020 were identified via the nationwide Pacemaker Registry. Data was crossmatched with the population registry and national disease registries. Primary outcome was new-onset HF within 5 years, and a risk score for this was developed and validated..ResultsIn all, 65579 patients met the inclusion criteria (10351 single chamber ventricular and 55228 dual chamber pacemakers). 13792 (21.0%) patients were diagnosed with HF within five years post-implant. Of these, 6244 (45.3%) were hospitalized for HF. Patients with new-onset heart failure were more likely to die within five years (41.2% vs. 19.7%, p<0.0001). Risk factors for new-onset HF included increasing age, male sex, hypertension, diabetes, atrial fibrillation, chronic lung- and kidney disease, ischemic heart disease, and AV block. In a combined score using these variables, patients in the highest risk-score quartile had a hazard ratio of 5.36 [4.91-5.86] (p<0.001) and an absolute risk of 32% for developing HF.ConclusionPacemaker therapy is associated with >20% risk of new-onset HF within five years, and we identified nine risk factors associated with the diagnosis of new-onset HF. The proposed score based on these variables can be used to identify patients at high risk for new-onset heart failure.
No takes yet. Share an insight, caveat, or question.
Farouq et al. (2024) conducted a cohort in Pacemaker implantation without preexisting heart failure (n=65,579). Pacemaker implant was evaluated on New-onset HF within 5 years (HR 5.36, 95% CI 4.91-5.86, p=<0.001). Pacemaker implantation in patients without preexisting heart failure was associated with a 21.0% incidence of new-onset HF within 5 years; the highest risk-score quartile had an HR of 5.36.
Synapse has enriched 10 related papers. Consider them for comparative context: